ArticleJTCVS techniques2025
Safety and efficacy of the neo-modified cabrol procedure with cabrol-fistula in 469 patients with low coronary ostia aortic root aneurysm.
Article in JTCVS techniques, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Posterior Teflon-Felt-Reinforced Coronary Button Anastomosis in a Modified Bentall Procedure: Early Outcomes in a Single-Center Retrospective Study.Journal of clinical medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: The study objectives were to evaluate the clinical efficacy, safety, and applicability of the neo-modified Cabrol procedure. Methods: This study uses a retrospective cohort design of 469 patients who underwent the neo-modified Cabrol procedure between December 2012 and June 2023. Cross-sectional follow-up was performed between September 2023 and February 2024. The fate of the coronary interposition graft was evaluated by reviewing the data and images from computed tomography angiography of the aorta and coronary arteries of the follow-up patients. Results: A total of 469 patients (mean age 53.7 ± 10.7 years; 409 male and 60 female patients) were included. The mean follow-up was 3.14 years (range, 0.00-9.95 years) for a total of 1472.84 patient-years. All-cause mortality rate within 30 days was 2.6% (n = 12). Outpatient/telephone/WeChat follow-up was completed by 100% of discharged patients (n = 457). Actuarial survivals were 95.9% ± 0.1%, 89.4% ± 0.2%, and 78.1% ± 0.6% at 1, 5, and 10 years, respectively. There were no neo-modified Cabrol procedure interposition graft-related complications, such as coronary fistula, pseudoaneurysm, graft twisting, stenosis, occlusion, or thrombosis. Conclusions: The neo-modified Cabrol procedure is a safe and effective approach, offering favorable perioperative outcomes and long-term graft patency. Multicenter randomized controlled trials are needed to comprehensively evaluate the effectiveness of this technique.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.